USD
+$0.00
(+0.00%
)At Close (As of Sep 5, 2025)
$1.54B
Market Cap
-
P/E Ratio
-3.59
EPS
$51.61
52 Week High
$18.53
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | - |
Total Revenue | $0 |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$167M |
Selling General And Administrative | $41M |
Research And Development | $126M |
Operating Expenses | $167M |
Investment Income Net | - |
Net Interest Income | $13M |
Interest Income | $21M |
Interest Expense | $7.6M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | -$7.4M |
Income Before Tax | -$152M |
Income Tax Expense | $1K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$152M |
Comprehensive Income Net Of Tax | - |
Ebit | -$160M |
Ebitda | -$167M |
Net Income | -$152M |
Field | Value (USD) |
---|---|
Total Assets | $656M |
Total Current Assets | $651M |
Cash And Cash Equivalents At Carrying Value | $93M |
Cash And Short Term Investments | $93M |
Inventory | - |
Current Net Receivables | $3.8M |
Total Non Current Assets | $4.5M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $548M |
Other Current Assets | $6.6M |
Other Non Current Assets | - |
Total Liabilities | $79M |
Total Current Liabilities | $25M |
Current Accounts Payable | $7.7M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $1.5M |
Total Non Current Liabilities | $53M |
Capital Lease Obligations | $4M |
Long Term Debt | $51M |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $55M |
Other Current Liabilities | $16M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $577M |
Treasury Stock | - |
Retained Earnings | -$461M |
Common Stock | $64K |
Common Stock Shares Outstanding | $55M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$135M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $105K |
Capital Expenditures | $972K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$425M |
Cashflow From Financing | $607M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$13K |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$152M |
Field | Value (USD) |
---|---|
Gross Profit | - |
Total Revenue | $0 |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$167M |
Selling General And Administrative | $41M |
Research And Development | $126M |
Operating Expenses | $167M |
Investment Income Net | - |
Net Interest Income | $13M |
Interest Income | $21M |
Interest Expense | $7.6M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | -$7.4M |
Income Before Tax | -$152M |
Income Tax Expense | $1K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$152M |
Comprehensive Income Net Of Tax | - |
Ebit | -$160M |
Ebitda | -$167M |
Net Income | -$152M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases in the United States. The company is headquartered in South San Francisco, California.